Efficacy of a multistrain synbiotic treatment in post-acute COVID-19 patients: A double-blind, Placebo-Controlled Randomized trial
In this randomised, double-blind, placebo-controlled trial 52 COVID-19 patients  were randomly assigned  to receive a multistrain synbiotic formula or placebo, in order to assess any impact of microbiota manipulation on acute and post-acute symptoms.
In this randomised, double-blind, placebo-controlled trial 52 COVID-19 patients  were randomly assigned  to receive a multistrain synbiotic formula or placebo, in order to assess any impact of microbiota manipulation on acute and post-acute symptoms.
European Bioinformatics Institute